Martin Shkreli, the controversial pharmaceutical millionaire who recently purchased the Wu-Tang Clan's Once Upon a Time in Shaolin for $2 million, has announced that he's considering posting bail for the incarcerated Brooklyn rapper Bobby Shmurda.

In a conversation with HipHopDX, Shkreli, who has been vocal about his love for hip-hop and who says he one day hopes to record a rap album, said that he's currently in talks to post bond for the rapper, who has been denied bail no fewer than six times since he was arrested last December.

"Forget whether you think he’s guilty or not," Shkreli said. "The guy should not be sitting in jail right now. It’s insane. He’s from Brooklyn. I’m from Brooklyn. He deserves a fair trial. He deserves good lawyers. He doesn’t have good lawyers. His label is hanging him out to dry." Though Epic Records and its CEO, L.A. Reid, have come under fire for failing to bail Shmurda out of jail, Reid explained this fall his decision-making process, calling Epic's actions "fair practice."

None of this is to say that the gesture--which is no sure thing, given the course Shmurda's legal odyssey has taken--would come without strings. I’m not going to do this for free," Shkreli said. "[Shmurda]’s going to have to do something for me. I don’t know what that’s going to look like yet. He’s going to owe me one, obviously. I’d like to pay for his legal defense as well. I’m a big fan but also I’m an opportunist. You know that. I see an opportunity here."

Shkreli, who co-founded and serves as CEO for Turing Pharmaceuticals, was the target of considerable criticism this fall when he acquired the license for Daraprim, a medication used to help treat HIV patients and to treat and prevent malaria, often in developing countries. Upon acquiring the license, Skreli raised the price of the drug from $13.50 per tablet to $750 per tablet, an increase of 5,500 percent.

See Best Rap Performance Nominees & Winners at the Grammys Over the Years